NHL
Showing NaN - NaN of 3
Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab
Withdrawn
- Non Hodgkin's Lymphoma
- +3 more
- Veltuzumab and 90Y-Epratuzumab Tetraxetan
- +2 more
-
Newark, Delaware
- +6 more
Aug 12, 2021
CML, AML, MDS Trial in Philadelphia (Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells, Observation Arm)
Completed
- CML
- +6 more
- Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
- Observation Arm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 17, 2016